title: Excluding Anti-cytomegalovirus Immunoglobulin M-Positive Cord Blood Units Has a Minimal Impact on the Korean Public Cord Blood Bank Inventory.
abstract: Cord blood units (CBUs) for transplantation should be free of communicable disease and must contain a specific amount of total nucleated cells and CD34+ cells. Although posttransplantation cytomegalovirus (CMV) infections are from latent infection in patients, ensuring CMV-free CBUs by performing CMV-specific IgM and nucleic acid amplification testing (NAT) is one of the mandatory procedures for the safety of CBUs. However, the exclusion policies (based on these test results) vary among nations and institutions. We tested 28,000 processed CBUs between May 2006 and June 2014. The cord blood leukocytes from CMV IgM-positive samples were then subjected to NAT. The total nucleated cell and CD34+ cell counts were measured for each CBU, and the results were compared to the CMV IgM and IgG results. The seroprevalence of CMV among pregnant women was 98.1% (18,459/18,818) for IgG and 1.7% (441/25,293) for IgM. The concentration and the total number of CD34+ cells were significantly higher in CBUs from IgM-negative mothers compared to those from IgM-positive mothers (72.4/μl vs. 57.2/μl, respectively, p < 0.0001; 1.45 × 106/unit vs. 1.15 × 106/unit, respectively, p < 0.0001). Among CBUs with positive CMV IgM in their mothers' plasma or cord blood plasma, only 0.58% of the samples (3/517) had a positive NAT. The number of excluded CBUs from inventory due to positive CMV IgM in the cord blood was 54 of 18,326 (0.3%). For inventory purposes, it is appropriate to remove CBUs with positive cord blood CMV IgM findings irrespective of the NAT status as well as positive maternal CMV IgM in South Korea.
authors.forename: Sue
authors.initials: S
authors.lastname: Shin
authors.forename: Eun Youn
authors.initials: EY
authors.lastname: Roh
authors.forename: Sohee
authors.initials: S
authors.lastname: Oh
authors.forename: Eun Young
authors.initials: EY
authors.lastname: Song
authors.forename: Eui Chong
authors.initials: EC
authors.lastname: Kim
authors.forename: Jong Hyun
authors.initials: JH
authors.lastname: Yoon
mesh_terms: D000914:Antibodies, Viral / Q000276:immunology; D018952:Antigens, CD34 / Q000378:metabolism; D000094902:Blood Banking / Q000379:methods*; D003587:Cytomegalovirus / Q000276:immunology* / Q000472:pathogenicity; D005260:Female; D005312:Fetal Blood / Q000821:virology*; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D007075:Immunoglobulin M / Q000276:immunology; D016014:Linear Models; D011247:Pregnancy; D056910:Republic of Korea
chemical_list: D000914:Antibodies, Viral; D018952:Antigens, CD34; D007074:Immunoglobulin G; D007075:Immunoglobulin M